These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38041514)

  • 1. The German version of the tablet-based UCSF Brain Health Assessment is sensitive to early symptoms of neurodegenerative disorders.
    Gianina T; Lorena S; Dilaxy K; Patrick C; Florian K; Thomas M; Ursi K; Andreas UM; Kate P; Rankin KP; Felbecker A
    Brain Behav; 2023 Dec; 13(12):e3329. PubMed ID: 38041514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Brain Health Assessment for Detecting and Diagnosing Neurocognitive Disorders.
    Possin KL; Moskowitz T; Erlhoff SJ; Rogers KM; Johnson ET; Steele NZR; Higgins JJ; Stiver J; Alioto AG; Farias ST; Miller BL; Rankin KP
    J Am Geriatr Soc; 2018 Jan; 66(1):150-156. PubMed ID: 29355911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults.
    Rodríguez-Salgado AM; Llibre-Guerra JJ; Tsoy E; Peñalver-Guia AI; Bringas G; Erlhoff SJ; Kramer JH; Allen IE; Valcour V; Miller BL; Llibre-Rodríguez JJ; Possin KL
    J Alzheimers Dis; 2021; 79(1):85-94. PubMed ID: 33216033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of the Ascertain Dementia 8 (AD8) Thai version.
    Thaipisuttikul P; Nakawiro D; Kuladee S; Chittaropas P; Sukying C
    Psychogeriatrics; 2022 Nov; 22(6):795-801. PubMed ID: 36319270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the Polish versions of the Montreal Cognitive Assessment 7.2 and the Mini-Mental State Examination as screening instruments for the detection of mild neurocognitive disorder.
    Sokołowska N; Sokołowski R; Oleksy E; Kasperska P; Klimkiewicz-Wszelaki K; Polak-Szabela A; Podhorecka M; Kędziora-Kornatowska K
    Neurol Neurochir Pol; 2020; 54(5):440-448. PubMed ID: 32808669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Montreal Cognitive Assessment-Basic in a sample of elderly Egyptians with neurocognitive disorders.
    Saleh AA; Alkholy RSAEHA; Khalaf OO; Sabry NA; Amer H; El-Jaafary S; Khalil MAEF
    Aging Ment Health; 2019 May; 23(5):551-557. PubMed ID: 29424560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effectiveness of the Montreal Cognitive Assessment 7.2 and the Mini-Mental State Examination in the detection of mild neurocognitive disorder in people over 60 years of age. Preliminary study.
    Sokołowska N; Sokołowski R; Polak-Szabela A; Mazur E; Podhorecka M; Kędziora-Kornatowska K
    Psychiatr Pol; 2018 Oct; 52(5):843-857. PubMed ID: 30584818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Hemrungrojn S; Tangwongchai S; Charoenboon T; Panasawat M; Supasitthumrong T; Chaipresertsud P; Maleevach P; Likitjaroen Y; Phanthumchinda K; Maes M
    Dement Geriatr Cogn Disord; 2021; 50(2):183-194. PubMed ID: 34325427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of a Self-Administered Online Cognitive Assessment in Detecting Amnestic Mild Cognitive Impairment.
    Paterson TSE; Sivajohan B; Gardner S; Binns MA; Stokes KA; Freedman M; Levine B; Troyer AK
    J Gerontol B Psychol Sci Soc Sci; 2022 Feb; 77(2):341-350. PubMed ID: 34333629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurocognitive disorder cohort RIFADE: Aims, methods, first results showing cognitive improvement in a subgroup.
    Baumann B; Lipka T; Jänner M; Kujovic M
    Eur Arch Psychiatry Clin Neurosci; 2023 Jun; 273(4):941-952. PubMed ID: 36416960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Montreal Cognitive Assessment (Hong Kong Version) in the Diagnosis of Mild Neurocognitive Disorders (NCD): NCD due to Alzheimer Disease (NCD-AD) and NCD due to Vascular Disease (NCD-Vascular).
    Lu H; Chan SS; Fung AW; Lam LC
    J Am Med Dir Assoc; 2016 Apr; 17(4):366-7. PubMed ID: 26884107
    [No Abstract]   [Full Text] [Related]  

  • 13. Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.
    Kaya Y; Aki OE; Can UA; Derle E; Kibaroğlu S; Barak A
    J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):103-9. PubMed ID: 24578463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to the Letter from Lu et al, "Utility of Montreal Cognitive Assessment (Hong Kong Version) in the Diagnosis of Mild Neurocognitive Disorders (NCD): NCD Due to Alzheimer Disease (NCD-AD) and NCD Due to Vascular Disease (NCD-Vascular)".
    Liew TM; Yap P; Feng L; Gao Q; Ng TP
    J Am Med Dir Assoc; 2016 Apr; 17(4):367. PubMed ID: 26907663
    [No Abstract]   [Full Text] [Related]  

  • 15. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.
    Lam B; Middleton LE; Masellis M; Stuss DT; Harry RD; Kiss A; Black SE
    J Am Geriatr Soc; 2013 Dec; 61(12):2181-2185. PubMed ID: 24320735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How common are neurocognitive disorders in patients with chronic kidney disease and diabetes? Results from a cross-sectional study in a community cohort of patients in North Wales, UK.
    Hobson P; Lewis A; Nair H; Wong S; Kumwenda M
    BMJ Open; 2018 Dec; 8(12):e023520. PubMed ID: 30518585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montreal Cognitive Assessment (MoCA) Performance and Domain-Specific Index Scores in Amnestic
    Wood JL; Weintraub S; Coventry C; Xu J; Zhang H; Rogalski E; Mesulam MM; Gefen T
    J Int Neuropsychol Soc; 2020 Oct; 26(9):927-931. PubMed ID: 32423505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond a Differential Diagnosis: Cognitive and Morphometric Decoding of Information Processing Speed in Senior Adults with DSM-5 Mild Neurocognitive Disorders.
    Lu H; Chan SSM; Fung AWT; Lam LCW
    J Alzheimers Dis; 2017; 58(3):927-937. PubMed ID: 28527207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric Symptoms in Patients with Neurocognitive Disorder and Their Performance Between Mild and Major Stages.
    Botero-Rodríguez F; Córdoba Sastoque AM; Santacruz Escudero JM; Santamaría-García H
    J Alzheimers Dis; 2022; 85(4):1735-1744. PubMed ID: 34958035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric and Cognitive Subtypes among Community-Dwelling Older Persons and the Association with DSM-5 Mild Neurocognitive Disorder: Latent Class Analysis.
    Liew TM; Yu J; Mahendran R; Ng TP; Kua EH; Feng L
    J Alzheimers Dis; 2018; 62(2):675-686. PubMed ID: 29480192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.